Wells Fargo & Company »

Kiniksa Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals (KNSA) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Kiniksa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $186k 11k 17.54
2023-09-30 $590k 34k 17.37
2023-06-30 $464k 33k 14.08
2022-12-31 $13k 894 14.98
2022-09-30 $17k 1.2k 13.54
2022-06-30 $15k 1.5k 9.62
2022-03-31 $39k 3.9k 10.02
2021-12-31 $166k 14k 11.74
2021-09-30 $216k 19k 11.43
2021-06-30 $710k 33k 21.74
2021-03-31 $2.2M 120k 18.51
2020-12-31 $1.3M 72k 17.68
2020-09-30 $756k 49k 15.31
2020-06-30 $1.0M 40k 25.46
2020-03-31 $150k 9.7k 15.51
2019-12-31 $86k 7.8k 11.01
2019-09-30 $66k 7.8k 8.46
2019-06-30 $99k 7.3k 13.58
2019-03-31 $245k 14k 18.11
2018-12-31 $273k 9.7k 28.05
2018-09-30 $23k 917 25.08